A recent study focused on Medicare beneficiaries who survived drug overdoses in 2020 revealed that many were more likely to receive opioid painkillers than addiction treatments, leading to subsequent nonfatal overdoses and deaths. Researchers found gaps in providing necessary medications like buprenorphine and naloxone, crucial for overdose prevention. Effective interventions post-overdose include medications for opioid use disorder and behavioral health support, significantly reducing overdose mortality. However, only a small percentage of beneficiaries received these interventions promptly, indicating significant gaps in care that need addressing to prevent further overdoses and deaths.